Industry

DUBLIN–(BUSINESS WIRE)–The “Cystic Fibrosis Market Share, Size, Trends By Drug Class, Route of Administration, By Distribution Channel, By Region, Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global cystic fibrosis market is expected to reach USD 37.04 billion by 2030, rising at a CAGR of 24.3% over the forecast period. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Kidney Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Kidney Transplant Rejection (Immunology) pipeline landscape. Kidney transplantation is a therapy performed to replace a diseased kidney with a healthy kidney … [Read more…]

HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the GHOST 3D-Printed Titanium Spacer Systems. GHOST 3D-Printed Titanium Spacer System expands on Life Spine’s … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Next-Generation Sequencing Technology Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028” report has been added to ResearchAndMarkets.com’s offering. The report on the global next-generation sequencing technology market provides qualitative and quantitative analysis for the period from 2022 to 2028. The report predicts the global next-generation sequencing technology market to … [Read more…]

DrySee, a patented film dressing with a colorimetric indicator, could help reduce infections HOUSTON–(BUSINESS WIRE)–DrySee®, a medical technology company dedicated to improving wound care, created the first patented wound dressing that will change colors to indicate it should be changed. DrySee was the focus of a new clinical study published in the September issue of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Respiratory Drugs and Devices Market Research and Forecast, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global respiratory drugs and devices market is growing at a CAGR of 7.2% during the forecast period. Companies Mentioned Astrazeneca Adamis (Admp) Ads Biotechnology Air Liquide Alung Technologies Alvogen Anaxsys Applied Biocode Inc. Avita Medical … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–#CertaintySavesLives–Certis Oncology Solutions, a life science technology company, announced today the release of its new cancer model database, BarneyOI™. This proprietary, online repository houses deep molecular characterization data for Certis’ expanding bank of patient-derived xenograft (PDX) tumor models and cancer cell lines. With enhanced search features and user interface, BarneyOI gives cancer researchers … [Read more…]

Company to present Phase 1 data from its lead program, MDK-703, an Interleukin-7 (IL-7) mimetic with an extended half-life Additional poster showcases preclinical proof-of-concept data characterizing MDK-1654, a differentiated synthetic peptide that is both an IL-7 receptor and non-alpha IL-2/15 receptor agonist MENLO PARK, Calif.–(BUSINESS WIRE)–Medikine, Inc., a biopharmaceutical company developing transformative therapeutics for cancer, … [Read more…]

FDA clears way for human trials of BIO 300 to mitigate erectile dysfunction in men undergoing radiation treatment for prostate cancer MINNEAPOLIS–(BUSINESS WIRE)–Humanetics Corporation (Humanetics) announced today that it has received FDA clearance of its Investigational New Drug (IND) application for BIO 300 to mitigate erectile dysfunction in men undergoing radiation treatment for prostate cancer. … [Read more…]

HonorHealth and United Hospital Center Earn Distinctions SAN ANTONIO–(BUSINESS WIRE)–#COVID19–Harmful pathogens remain on commonly touched surfaces, even after the best liquid chemical cleaning efforts. As healthcare facilities battle viruses, bacteria and spores that can lurk on high-touch surfaces, proactive hospitals have invested in powerful UV-C disinfection technology to destroy pathogens missed during the manual room … [Read more…]